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Introduction {#jah31929-sec-0004}
============

Out‐of‐hospital cardiac arrest is a major public health issue with very poor prognosis and neurological outcome. Chances of survival are extremely low when return of spontaneous circulation (ROSC) is not obtained within 15 to 20 minutes of collapse, despite pursuit of cardiopulmonary resuscitation (CPR).[1](#jah31929-bib-0001){ref-type="ref"} In order to improve this prognosis, extracorporeal CPR (ECPR) has recently emerged as a promising therapy for the management of "refractory cardiac arrest."[2](#jah31929-bib-0002){ref-type="ref"}, [3](#jah31929-bib-0003){ref-type="ref"} In selected patients, ECPR was shown to increase the chances of ROSC through hemodynamic support and body oxygenation.[4](#jah31929-bib-0004){ref-type="ref"} As an example, Maekawa et al reports 3‐month survival rates as high as 29% with ECPR versus 8% with conventional CPR after out‐of‐hospital cardiac arrest of cardiac origin.[5](#jah31929-bib-0005){ref-type="ref"} Use of ECPR is now suggested for management of refractory cardiac arrest in the most recent American Heart Association guidelines for CPR and emergency cardiovascular care.[6](#jah31929-bib-0006){ref-type="ref"}

Beyond the necessity to obtain ROSC, it is also crucial to properly treat the underlying cause of the cardiac arrest. Acute coronary syndrome is the most common etiology, especially in patients presenting out‐of‐hospital cardiac arrest with initial shockable rhythms. In this situation, immediate percutaneous coronary intervention was associated with better survival.[7](#jah31929-bib-0007){ref-type="ref"}, [8](#jah31929-bib-0008){ref-type="ref"}, [9](#jah31929-bib-0009){ref-type="ref"}, [10](#jah31929-bib-0010){ref-type="ref"} However, these studies were performed in patients successfully resuscitated with conventional CPR. In the case of refractory cardiac arrest and ECPR, the most recent guidelines do not dictate the prioritization of care, between hemodynamic stabilization in the intensive care unit or rapid transfer to the catheterization laboratory, if a coronary occlusion is suspected. Although immediate coronary reperfusion is recommended if underlying acute myocardial infarction is suspected, little evidence is available during ECPR.[11](#jah31929-bib-0011){ref-type="ref"}, [12](#jah31929-bib-0012){ref-type="ref"}

In the present study, we attempted to determine whether coronary reperfusion should be done as early as possible during ECPR to improve resuscitation efficacy and cardiovascular outcomes in a porcine model of ischemic refractory cardiac arrest. We hypothesized that early reperfusion could facilitate ROSC and improve hemodynamic status. Accordingly, we compared the effect of an early versus late coronary reperfusion during ECPR. We evaluated hemodynamic and biochemical parameters, as well as infarct size. Importantly, myocardial infarction is known to expand much faster in pigs[13](#jah31929-bib-0013){ref-type="ref"} than humans and nonhuman primates.[14](#jah31929-bib-0014){ref-type="ref"} In this experimental study, we therefore used an accelerated time frame of ischemia and reperfusion as compared to the typical clinical situation and timing. "Early" reperfusion was considered after a total duration of ≈40 minutes of coronary artery occlusion, as compared to 140 minutes in the "late" reperfusion group. This was expected to induce an infarct size of ≈50% to 60% of the risk zone versus more than 80% in both conditions, respectively.

Materials and Methods {#jah31929-sec-0005}
=====================

The protocol was approved by the French national ethical committee no. 16 (agreement 14/04/15‐6). Animals were hosted in a conventional animal room.

Animal Preparation {#jah31929-sec-0006}
------------------

Eighteen female pigs crossed between Large White and Landrace were anesthetized with a mixture of ketamine (20 mg/kg, intramuscularly), acepromazine (0.25 mg/kg, intramuscularly), pentobarbital (10 mg/kg, intravenously) and buprenorphine was administered for analgesia (100 μg/kg, intravenously). They were intubated and submitted to conventional mechanical ventilation (FiO~2~=30%; tidal volume=10 mL/kg; respiratory rate=15--18 cycles/min). They were then instrumented with a carotid output flow probe (PS‐Series Probes, Transonic, NY), 2 fluid‐filled catheters into the left carotid artery and right atrium, and a hand‐made pneumatic occluder around the proximal left descending coronary artery. Two cannulae were also inserted into the right femoral vessels, 1 arterial (15F) and 1 venous (19F; HLS; Maquet, Rastatt, Germany) for further implementation of ECPR. Rectal temperature was maintained at 38.0±0.5°C. Throughout the protocol, carotid blood flow (Flowmeter‐TS420; PS‐Series Probes), arterial blood pressure, and electrocardiogram (ECG) were continuously recorded. Arterial blood samples were collected at baseline and 60 and 240 minutes after ECPR initiation.

Experimental Protocol {#jah31929-sec-0007}
---------------------

The experimental protocol is illustrated in Figure [1](#jah31929-fig-0001){ref-type="fig"}. After surgical preparation and stabilization, the pericoronary occluder was inflated to induce coronary artery occlusion. Two minutes later, ventricular fibrillation was induced by passing a transthoracic alternating current (30 V). Ventricular fibrillation was left untreated for 5 minutes, after which conventional CPR was initiated by continuous external chest compressions using an automated device (100 compressions/min; Thumper; Michigan Instruments, Grand Rapids, MI) and asynchronous ventilation (FiO~2~=100%; respiratory rate=9 cycles/min). After 15 minutes of conventional CPR, animals were shifted to ECPR using a transportable device (Cardiohelp; Maquet). Accordingly, circuit and membrane oxygenator (HLS; Maquet) were primed and heparinized (5000 IU). Extracorporeal blood flow was progressively increased to 50 to 60 mL/kg/min to optimize blood flow and reach the highest possible mean arterial pressure. After 10 minutes of ECPR, animals were divided into 2 experimental groups randomly submitted to early or late coronary reperfusion by deflation of the pericoronary occluder after 20 or 120 minutes of ECPR, respectively. ECPR was maintained for a total duration of 240 minutes. In both groups, fluids were administered using 13 mL/kg of blood and 500 mL/h of saline 0.9%. Norepinephrine was also administered at a fixed rate of 10 μg/kg/min. External defibrillation was attempted every 5 minutes during the first 15 minutes of ECPR and then every 15 minutes until successful defibrillation. As previously described, return of spontaneous heart beat (ROSB) was defined as successful defibrillation with organized ventricular contraction.[15](#jah31929-bib-0015){ref-type="ref"} ROSC was defined as an organized ECG rhythm with a systolic blood pressure above 80 mm Hg[12](#jah31929-bib-0012){ref-type="ref"}, [15](#jah31929-bib-0015){ref-type="ref"}, [16](#jah31929-bib-0016){ref-type="ref"} until the end of the protocol. ECPR blood flow was maintained as high as possible to avoid hypotension, whereas it was progressively decreased if ROSC occurred. During ECPR, animals were ventilated with low tidal volumes (7 mL/kg; FiO~2~=21%) and respiratory rate (10 cycles/min) until ROSB. After ROSB, respiratory parameters were modified depending on blood gases results. At the end of the protocol, animals were sacrificed and the heart was removed for pathological analyses. Myocardial risk zone and infarct size were determined using Evans blue perfusion and triphenyltetrazolium chloride staining, respectively.

![Experimental protocol (A), number of animals eliciting return of spontaneous heart beat (ROSB; B) and number of animals eliciting return of spontaneous circulation (ROSC; C) during extracorporeal cardiopulmonary resuscitation (ECPR). ROSB was defined as successful defibrillation with organized ventricular contraction. ROSC was defined as an organized rhythm with a systolic blood pressure above 80 mm Hg. In (B and C), solid and dashed lines represent the number of animals that achieved ROSC or ROSB in the early versus late reperfusion group, respectively. CAO indicates coronary artery occlusion; CPR, cardiopulmonary resuscitation.](JAH3-5-e004588-g001){#jah31929-fig-0001}

Investigated Parameters {#jah31929-sec-0008}
-----------------------

The primary endpoint of the study was the rate of ROSC. The secondary endpoints were the rate of ROSB, ECPR flow, infarct size, and carotid blood flow, as a predictor of subsequent neurological sequelae.[17](#jah31929-bib-0017){ref-type="ref"}, [18](#jah31929-bib-0018){ref-type="ref"} We also investigated arterial blood gases and blood levels of lactate, creatinine, troponine I, protein S100 (PS100), and alanine aminotransferase (ALAT).

Statistical Analyses {#jah31929-sec-0009}
--------------------

Data are expressed as mean±SEM. ROSC and ROSB occurrence were compared between groups using a log‐rank analysis throughout follow‐up. Body weight and infarct size were compared using an unpaired Student *t* test. Hemodynamic parameters were compared using a 2‐way ANOVA for repeated measures with a Fisher\'s least significant difference post‐hoc analysis. ANOVA took into account the group effect, time effect, and their interaction. Two distinct analyses were performed (ie, before and after randomization, respectively). The first analysis was performed with values acquired with the following time points: baseline, CPR, and early ECPR. Corresponding post‐hoc analyses were only performed between groups, and between CPR and ECPR, in order to avoid multiple comparisons. The second analysis was performed after randomization and successful defibrillation of all animals with the following time points: 180 and 240 minutes of ECPR. Post‐hoc analyses were then only performed between groups. Finally, biochemical parameters were compared with a Mann--Whitney test at baseline and 60 and 240 minutes after ECPR institution. Analyses were performed using Sigma Stat 3.5 (Systat Software Inc., Chicago, IL). Significant differences were determined at *P*≤0.05.

Results {#jah31929-sec-0010}
=======

Baseline Characteristics {#jah31929-sec-0011}
------------------------

Eighteen swine were enrolled in the present study. Among them, 4 were excluded for technical issues during instrumentation. Fourteen animals were ultimately submitted to ECPR in the 2 experimental groups (ie, 7 animals in both early and late reperfusion groups). Body weights were similar between groups (31.8±1.7 vs 31.7±0.7 kg, respectively), as well as baseline values of hemodynamic and biochemical parameters (Tables [1](#jah31929-tbl-0001){ref-type="table-wrap"} and [2](#jah31929-tbl-0002){ref-type="table-wrap"}). Mean arterial pressure and carotid blood flow were also not different between groups during conventional CPR.

###### 

Hemodynamic Parameters in Both Groups at Baseline, During Conventional CPR and 10 Minutes After Initiation of ECPR, That Is, Before Reperfusion and ROSB

  Parameters and Groups                    Baseline   Conventional CPR (t=10 minutes)   ECPR (t=10 minutes)   *P* Value\*
  ---------------------------------------- ---------- --------------------------------- --------------------- -------------
  No. of animals                                                                                              
  Early reperfusion                        7          7                                 7                     ---
  Late reperfusion                         7          7                                 7                     
  Mean arterial blood pressure, mm Hg                                                                         
  Early reperfusion                        77±4       32±3                              48±5                  \<0.001
  Late reperfusion                         81±5       33±4                              46±2                  
  Maximal arterial blood pressure, mm Hg                                                                      
  Early reperfusion                        91±4       62±8                              55±8                  0.148 (NS)
  Late reperfusion                         97±6       66±16                             49±3                  
  Minimal arterial blood pressure, mm Hg                                                                      
  Early reperfusion                        65±3       9±5                               45±4\*                \<0.001
  Late reperfusion                         69±4       8±4                               44±2\*                
  Carotid blood flow, mL/min                                                                                  
  Early reperfusion                        342±33     87±10                             150±21\*              0.012
  Late reperfusion                         332±22     89±19                             140±25\*              
  ECPR blood flow, L/min                                                                                      
  Early reperfusion                        ---        ---                               1.9±0.1               ---
  Late reperfusion                         ---        ---                               1.7±0.2               
  Heart rate, bpm                                                                                             
  Early reperfusion                        138±18     ---                               ---                   ---
  Late reperfusion                         122±11     ---                               ---                   

*P* value represents time effect between ECPR and conventional CPR. No group effect was observed these time points (ie, before group allocation after 10 minutes of ECPR). No comparison was performed versus baseline. Data are expressed as mean±SEM. CPR indicates cardiopulmonary resuscitation; ECPR, extracorporeal cardiopulmonary resuscitation; NS, not significant; ROSB, return of spontaneous beats.

\**P*\<0.05 between conventional CPR and ECPR.

###### 

Biochemical Parameters in Both Groups Throughout Protocol

  Parameters and Groups             Baseline    ECPR (t=60 minutes)   ECPR (t=240 minutes)   *P* Value
  --------------------------------- ----------- --------------------- ---------------------- ------------
  No. of animals                                                                             
  Early reperfusion                 7           7                     7                      
  Late reperfusion                  7           7                     7                      
  Arterial pH                                                                                
  Early reperfusion                 7.36±0.02   7.13±0.04             7.05±0.01              0.620 (NS)
  Late reperfusion                  7.36±0.02   7.14±0.03             7.05±0.02              
  Arterial pCO~2~, mm Hg                                                                     
  Early reperfusion                 45±2        44±4                  34±4                   0.128 (NS)
  Late reperfusion                  45±2        45±4                  26±4                   
  Arterial pO~2~, mm Hg                                                                      
  Early reperfusion                 147±2       354±80                295±83                 0.097 (NS)
  Late reperfusion                  137±7       289±75                460±73                 
  Blood lactates levels, mmol/L                                                              
  Early reperfusion                 3.0±1.6     10.0±2.0              11.9±2.7\*             0.038
  Late reperfusion                  1.9±0.1     11.4±0.6              16.7±1.0               
  Blood creatinine levels, mmol/L                                                            
  Early reperfusion                 146±30      210±29                171±3\*                0.038
  Late reperfusion                  130±6       207±12                238±15                 
  Blood ALAT levels, UI/L                                                                    
  Early reperfusion                 36.6±5.0    45.7±6.5              44.0±7.6               0.445 (NS)
  Late reperfusion                  41.7±3.9    51.7±6.5              54.8±10.4              
  Blood PS100 levels, μg/L                                                                   
  Early reperfusion                 0.71±0.08   ---                   2.78±0.48              0.535 (NS)
  Late reperfusion                  0.64±0.03   ---                   3.74±0.85              

*P* value represents group effect between Early and Late reperfusion groups at 240 minutes of ECPR. No significant group effect was observed at 60 minutes of ECPR. No comparison was performed among the different time points. Data are expressed as mean±SEM. ALAT indicates alanine aminotransferase; ECPR, extracorporeal cardiopulmonary resuscitation; LDH, lactate deshydrogenase; NS, not significant; PS100, protein S100.

\**P*\<0.05 vs "Late reperfusion" group.

ECPR Improves Hemodynamic Parameters as Compared to Conventional CPR {#jah31929-sec-0012}
--------------------------------------------------------------------

From the onset of ECPR, mean arterial pressure and carotid blood flow were increased as compared to conventional CPR (Table [1](#jah31929-tbl-0001){ref-type="table-wrap"}). Carotid blood flow achieved 150±21 mL/min with ECPR as compared to 87±10 mL/min with conventional CPR at t=10 minutes of ECPR in the early reperfusion group. This increase was a direct effect of ECPR because animals were not yet reperfused or defibrillated at this time point. As shown in Table [1](#jah31929-tbl-0001){ref-type="table-wrap"}, this initial improvement was similar in both groups, as expected, with similar ECPR flows at the beginning of the procedure (1.9±0.1 and 1.7±0.2 L/min in early and late reperfusion groups, respectively). Arterial pH and partial pressures of O~2~ and CO~2~ levels were not different among groups throughout the protocol (Table [2](#jah31929-tbl-0002){ref-type="table-wrap"}).

Early Reperfusion Allows ROSC During ECPR and Limits Shock Status {#jah31929-sec-0013}
-----------------------------------------------------------------

During ECPR prolongation, all animals progressively achieved ROSB after defibrillation attempts. Mean time to obtain ROSB was slightly shorter in the early versus late reperfusion group (48±17 vs 82±25 minutes, *P*=0.113), but the difference did not reach statistical significance. ROSB did not always lead to a better hemodynamic status given that ROSC was observed in 4 animals in the early reperfusion group versus 0 in the late reperfusion group (*P*=0.022 between groups). Arterial pressure was consistently improved in the early versus late reperfusion group (Figure [2](#jah31929-fig-0002){ref-type="fig"}). Importantly, this allowed a very rapid decrease of the ECPR flow after ROSB in the early reperfusion group (Figure [3](#jah31929-fig-0003){ref-type="fig"}). Two animals could be weaned from ECPR in this group.

![Heart rate and blood pressure after return of spontaneous heart beat (ROSB) during extracorporeal cardiopulmonary resuscitation (ECPR) in both groups. The number of animals with ROSB is shown on the first panel at each time point. Statistical analyses were performed at 180 minutes and 240 of ECPR, after which all animals achieved ROSB. *P* value corresponds to significant group effect at corresponding time point. No comparison was made among the different time points. Data are expressed as mean±SEM.](JAH3-5-e004588-g002){#jah31929-fig-0002}

![Carotid and extracorporeal cardiopulmonary resuscitation (ECPR) blood flow after resumption of spontaneous heart beat (ROSB) in both groups. Statistical analyses were only performed at 180 minutes and 240 of ECPR, after which all animals achieved ROSB. *P* value corresponds to significant group effect at corresponding time point. No comparison was made among the different time points. Data are expressed as mean±SEM.](JAH3-5-e004588-g003){#jah31929-fig-0003}

In the late reperfusion group, ECPR flow remained high and showed greater dependency on circulatory support. However, it was impossible to maintain high ECPR flow at the end of the follow‐up (240 minutes of ECPR), because a flow limitation occurred progressively attributed to the severe shock status and venous return limitation. No animals were weaned from ECPR in this group.

Early Reperfusion Improves Cerebral Perfusion After ECPR and Limits Myocardial Infarct Size {#jah31929-sec-0014}
-------------------------------------------------------------------------------------------

In line with improved hemodynamic status, carotid blood flow was significantly higher in the early versus late reperfusion group after ROSB (eg, 113±20 vs 43±17 mL/min in both groups at the end of the procedure, respectively; *P*=0.009). The decreased shock status in the early reperfusion group was also supported by the attenuation of lactate and creatinine blood levels at the end of the follow‐up as compared to late reperfusion. ALAT blood levels were not different among groups, but they elicited only a very mild increase after cardiac arrest. PS100 blood levels were also not significantly different between groups.

Importantly, infarct size was significantly reduced in the early versus late reperfusion group (71±4% vs 84±2%, respectively; *P*=0.013) despite a similar risk zone (31±3% vs 30±4%, respectively).

Discussion {#jah31929-sec-0015}
==========

The present study shows that early coronary reperfusion can improve hemodynamics and limit shock status during ECPR in a pig model of refractory cardiac arrest. This was shown by an improved rate of ROSC, enhanced cerebral perfusion, and reduced infarct size. The novelty of the study is to evaluate ECPR during experimental cardiac arrest with concomitant coronary artery occlusion and reperfusion. To our knowledge, previous experimental studies were performed in "non ischemic" hearts[13](#jah31929-bib-0013){ref-type="ref"}, [19](#jah31929-bib-0019){ref-type="ref"}, [20](#jah31929-bib-0020){ref-type="ref"} or without reperfusion.[12](#jah31929-bib-0012){ref-type="ref"} Our results suggest that revascularization should be prioritized during ECPR when an ischemic origin is suspected.

ECPR Is Efficient for the Treatment of Refractory Cardiac Arrest {#jah31929-sec-0016}
----------------------------------------------------------------

Experimental evidence on refractory cardiac arrest is rather scarce. Most studies were done in non ischemic refractory cardiac arrest, after which it has been well demonstrated that ECPR increases the chances of ROSC.[16](#jah31929-bib-0016){ref-type="ref"}, [19](#jah31929-bib-0019){ref-type="ref"}, [20](#jah31929-bib-0020){ref-type="ref"} Here, we confirm that ECPR improves hemodynamic parameters given that mean arterial pressure and carotid blood flow increased by more than 50% when compared with conventional CPR, respectively. In a previous report, Reynolds et al reported consistent results with a comparison of hemodynamic parameters during ECPR and conventional CPR in pigs submitted to 8 or 15 minutes of ventricular fibrillation and to 30 to 60 minutes of conventional CPR before ECPR.[16](#jah31929-bib-0016){ref-type="ref"} They showed that mean arterial pressure, coronary perfusion pressure, and amplitude spectrum area of ventricular fibrillation were significantly improved by ECPR. The rate of ROSC was also higher when animals underwent early ECPR, emphasizing the relevance of a rapid initiation of ECPR after cardiac arrest. Mlček et al also showed that hemodynamic and biological alterations could be rapidly restored when ECPR was started immediately after a prolonged cardiac arrest of 20 minutes in swine.[19](#jah31929-bib-0019){ref-type="ref"} This is consistent with recent clinical reports starting ECPR as early as possible after cardiac arrest.[21](#jah31929-bib-0021){ref-type="ref"}

To our knowledge, only 1 study was performed with ECPR after ischemic cardiac arrest in sheep.[12](#jah31929-bib-0012){ref-type="ref"} This study showed that ECPR was more efficient than conventional CPR to achieve ROSC, but the impact of reperfusion was not tested. In the present study, we attempted to mimic the typical clinical situation in which ECPR could be combined to reperfusion.[4](#jah31929-bib-0004){ref-type="ref"} Preliminary and unpublished data confirmed the severity of our model, which, in the absence of ECPR, led to unsuccessful CPR, even after prolonged conventional CPR and coronary revascularization. With ECPR, all animals were successfully defibrillated and obtained ROSB, again showing the potency of ECPR versus conventional CPR, independently from the time of reperfusion.

Reperfusion Is Essential After Cardiac Arrest, Even During ECPR {#jah31929-sec-0017}
---------------------------------------------------------------

In the present study, the major finding is the strong cardiovascular improvement with early versus late reperfusion during ECPR. In the group with late reperfusion, we chose a total duration of ischemia of more than 140 minutes, which led to high infarct size and minimal salvage at reperfusion in pigs.[22](#jah31929-bib-0022){ref-type="ref"} In such conditions, animals were initially defibrillated, but none achieved ROSC. A dramatic shock status was evidenced by a low arterial pressure, decreased cerebral perfusion, and high blood lactate levels, despite fluid and vasopressors administration. In addition, it was progressively impossible to maintain high ECPR flow given that venous return was insufficient. This could be related to a progressive no reflow that seems to occur after prolonged cardiac arrest given that thrombolytic drugs were shown to improve the outcome in pigs during ECPR.[15](#jah31929-bib-0015){ref-type="ref"} This shows that cardiovascular recovery was not possible in our study with late reperfusion, despite successful defibrillation after ECPR.

Importantly, we observed a dramatic contrast in the group with early reperfusion. In that group, reperfusion was started after 20 minutes of ECPR and a total ischemic duration of 42 minutes. This short duration was chosen to induce an infarction of ≈50% to 60% of the risk zone because infarct expands faster in pigs than humans.[13](#jah31929-bib-0013){ref-type="ref"} Interestingly, we observed higher infarct size than expected (71±4%) as a possible consequence of worsened infarction after cardiac arrest and ECPR. Therefore, the actual decrease in infarct size was limited with early versus late reperfusion (only −15%), but led to major improvements on systemic hemodynamics and cerebral perfusion. This allowed ROSC in 4 of 7 animals and weaning in 2/7 (vs 0 with late reperfusion). Overall, this demonstrates that ECPR potentiated by early reperfusion could lead to rapid cardiovascular improvement, whereas ECPR loses a large part of its benefit if reperfusion is delayed.

Sideris et al found similar results in pigs resuscitated after ischemic cardiac arrest and conventional CPR.[23](#jah31929-bib-0023){ref-type="ref"} In this study, early reperfusion increased survival and improved neurological recovery after 24 hours. More important, this is consistent with clinical reports showing that immediate coronary angiography improves survival in comatose victims of cardiac arrest after resuscitation with conventional CPR.[7](#jah31929-bib-0007){ref-type="ref"}, [8](#jah31929-bib-0008){ref-type="ref"} This was recently confirmed by a cohort study from the large PROCAT registry[8](#jah31929-bib-0008){ref-type="ref"} and a meta‐analysis.[9](#jah31929-bib-0009){ref-type="ref"}

Clinical Perspectives {#jah31929-sec-0018}
---------------------

Today, there are no guidelines regarding the immediate care of cardiac arrest patients undergoing ECPR. There is little clinical evidence of the necessity to obtain early reperfusion during post‐arrest ECPR.[11](#jah31929-bib-0011){ref-type="ref"} Indeed, patients can be very unstable and one might speculate that initial intensive care and stabilization should be done before revascularization. The present study suggests that revascularization should be done as early as possible to allow the cardiovascular benefits of ECPR. In other words, the patient should have a coronary angiography as soon as possible, supporting ECPR implementation as close as possible to a cath lab. The use of dedicated valves for cannula could also facilitate coronary angiography without need for repeated arterial access. It could be particularly relevant in patients with very poor pulsatility.

In a recent single‐center study, Stub et al demonstrated that the combination of ECPR, revascularization, and hypothermia[4](#jah31929-bib-0004){ref-type="ref"} could lead to a global survival rate with good neurological outcome as high as 54% in a limited number of patients with in‐ or out‐of‐hospital cardiac arrest (14 of 26 patients). It is now important to determine the individual benefit of each particular treatment. Prospective trials are now required to rationalize the treatments of those patients.

Study Limitations {#jah31929-sec-0019}
-----------------

Our study presents several limitations. As an example, we used a schematic design, which does not directly mimic the typical timeline in the clinical arena. As previously discussed, our rationale was mostly directed to obtain a certain level of infarct size, taking into account the rapid infarct expansion in pigs. Moreover, we were not able to follow the animals for a longer duration. Our goal was to investigate the acute hemodynamic parameters and not long‐term survival and neurological recovery. However, it was previously demonstrated that hemodynamic stability and improved carotid blood flow was somehow related to better survival and neurological outcome on the longer term.[17](#jah31929-bib-0017){ref-type="ref"}, [18](#jah31929-bib-0018){ref-type="ref"} Further studies will be required to confirm these findings after ECPR and refractory cardiac arrest.[24](#jah31929-bib-0024){ref-type="ref"}

Conclusion {#jah31929-sec-0020}
==========

In a porcine model of cardiac arrest, early coronary reperfusion was associated with better hemodynamic status and increased chances of ROSC during ECPR. This supports the use of rapid reperfusion in this situation, rather than delaying revascularization for hemodynamic stabilization. These findings support the need for clinical trials to confirm these results in patients.
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